AXGT
Axovant Gene Therapies Ltd.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Axovant Gene Therapies Ltd. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease. Axovant operates through seven wholly owned subsidiaries and also has business operations in Basel, Switzerland and New York, NY. The company was founded on October 31, 2014 and is headquartered in London, United Kingdom.
Market Cap: 84.7 Million
Primary Exchange: NASDAQ
Website: http://www.axovant.com
Shares Outstanding: 40.3 Million
Float: 24.4 Million
Dividend: (%)
Beta: 1.2077630990245243
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 404 trading days
From: 2019-05-08 To: 2020-11-12
Lowest Point:
SYBX, MAT among premarket gainers
via: SeekingAlpha at 2019-06-12 05:16:31:000
Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more … read more...
SYBX, MAT among premarket gainers
via: SeekingAlpha at 2019-06-12 05:16:31:000
Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more … read more...
PLAY leads after hours losers
via: SeekingAlpha at 2019-06-11 13:34:03:000
Gainers: MX +16.9% . AXGT +15.5% . MAT +8.7% . NBY +6.7% . NVTR +5.5% . More news on: MagnaChip Semiconductor Corporation, Axovant Gene Therapies Ltd., Mattel, Inc., Stocks on the move, , News on ETFs Read more … read more...
Axovant Gene Therapies reports Q4 results
via: SeekingAlpha at 2019-06-11 12:11:20:000
Axovant Gene Therapies (NASDAQ: AXGT ): Q4 GAAP EPS of -$0.45. More news on: Axovant Gene Therapies Ltd., Earnings news and commentary, , Read more … read more...
Axovant Gene Therapies (AXGT) Investor Presentation - Slideshow
via: SeekingAlpha at 2019-06-10 07:38:51:000
The following slide deck was published by Axovant Gene Therapies Ltd. in conjunction with this Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|